BCM
ZYNE

Beryl Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Beryl Capital Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,898,927
Closed -$6.25M – 41
2023
Q3 		$6.25M Buy
+4,898,927
New +$6.25M 0.7% 15